Nasonex (Mometasone Furoate)

Mometasone furoate is a synthetic glucocorticoid that binds to intracellular glucocorticoid receptors in nasal mucosal cells. This binding alters gene transcription, suppressing the production of pro‑inflammatory cytokines and chemokines and limiting recruitment of inflammatory cells, thereby decreasing swelling and mucus production in the nasal passages.

The specific dose of Nasonex is determined by the prescribing healthcare professional based on the patient’s age, condition and response to therapy. Typical regimens involve one or two sprays per nostril once daily, but the exact number of sprays and duration must follow the prescriber’s instructions.

Safety of mometasone furoate nasal spray in pregnancy has not been definitively established; it should only be used if the potential benefit justifies any potential risk to the fetus. Limited data are available for breastfeeding, and a prescriber should evaluate the risk‑benefit ratio before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Nasonex. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex (mometasone furoate) is a high‑potency intranasal glucocorticoid with a once‑daily dosing schedule, similar to fluticasone and budesonide. Compared with lower‑potency options, it may achieve symptom control with fewer sprays, but individual response and tolerability vary, so clinicians choose based on patient profile and preference.

Nasonex should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and direct sunlight. The spray bottle should be kept tightly closed when not in use, and any unused product should be discarded after the indicated expiry date.

Nasonex is administered as a nasal spray. The user should gently blow the nose, tilt the head slightly forward, insert the tip into one nostril, and press the actuator while breathing in gently through the nose. The same procedure is repeated for the other nostril if prescribed, and the nozzle should be cleaned regularly.

Although rare, serious adverse events can include adrenal suppression, severe allergic reactions such as anaphylaxis, fungal infections of the nasal passages, and perforation of the nasal septum. Patients should seek immediate medical attention if they experience symptoms like severe headache, visual changes, or persistent nosebleeds.

Nasonex is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated nasal infections, recent nasal surgery unless cleared by a surgeon, and in those for whom systemic corticosteroid exposure is contraindicated.